Product Description: Veralipride (Standard) is the analytical standard of Veralipride. This product is intended for research and analytical applications. Veralipride is a D2 receptor antagonist. It is an alternative antidopaminergic treatment for menopausal symptoms.
Formula: C17H25N3O5S
References: [1]Melis GB, et al. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. Obstet Gynecol. 1988 Nov;72(5):688-92./[2]Carranza-Lira S, et al. Actual status of veralipride use. Clin Interv Aging. 2010 Sep 7;5:271-6./[3]Valencia MH, e al. Safety of veralipride for the treatment of vasomotor symptoms of menopause. Menopause. 2014 May;21(5):484-92./[4]Franchignoni FP, et al. Parkinson syndrome induced by veralipride. Minerva Ginecol. 1995 Jun;47(6):277-9.
CAS Number: 66644-81-3
Molecular Weight: 383.46
Research Area: Neurological Disease
Target: Dopamine Receptor;Reference Standards
Deutsch
English
